Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1363 to 1412 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
682\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative homeodomain transcription factor 1. [source:swissprot;acc:q9ums5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8154.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8509.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04359\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 12. [source:refseq;acc:nm\_177424]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5552.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6217.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1197\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
683\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mg81 protein (fragment). [source:sptrembl;acc:q14830]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8154.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8509.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04359\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 1 (sh3 domain protein 2b) (extra eleven-nineteen leukemia fusion gene) (een) (een fusion partner of mll). [source:swissprot;acc:q99961]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7139.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7994.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11969\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
684\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
contactin precursor (glycoprotein gp135). [source:swissprot;acc:q12860]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8154.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8509.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04359\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 9 (eif-3 eta) (eif3 p116) (eif3 p110) (eif3b). [source:swissprot;acc:p55884]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4359.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4880.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11954\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
685\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
metaxin 1. [source:swissprot;acc:q13505]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
9327.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10442.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1195\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative homeodomain transcription factor 2; hypothetical protein dkfzp564f013. [source:refseq;acc:nm\_020432]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8154.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8509.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04359\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
686\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, gamma-1 subunit (ampk gamma-1 chain) (ampkg). [source:swissprot;acc:p54619]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6920.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7747.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
elovl family member 6, elongation of long chain fatty acids (fen1/elo2, sur4/elo3-like, yeast); long-chain fatty-acyl elongase. [source:refseq;acc:nm\_024090]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8268.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8629.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04358\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
687\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, catalytic alpha-2 chain (ec 2.7.1.-) (ampk alpha-2 chain). [source:swissprot;acc:p54646]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6920.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7747.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 4 (potassium channel kv1.4) (hk1) (hpcn2) (hbk4) (hukii). [source:swissprot;acc:p22459]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7810.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8150.66\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04357\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
688\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, catalytic alpha-1 chain (ec 2.7.1.-) (ampk alpha-1 chain). [source:swissprot;acc:q13131]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6920.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7747.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome b5 reductase b5r.2. [source:refseq;acc:nm\_016229]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8146.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8500.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04353\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
689\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, beta-2 subunit (ampk beta-2 chain). [source:swissprot;acc:o43741]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6920.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7747.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
paxillin. [source:swissprot;acc:p49023]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7804.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8143.54\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04343\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
690\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, gamma-3 subunit (ampk gamma-3 chain) (ampk gamma3). [source:swissprot;acc:q9ugi9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6920.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7747.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
chromosome x open reading frame 9; likely ortholog of mouse sh3 gene sly. [source:refseq;acc:nm\_018990]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8530.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8175.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04341\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
691\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, beta-1 subunit (ampk beta-1 chain) (ampkb). [source:swissprot;acc:q9y478]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6920.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7747.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sterol o-acyltransferase 2 (ec 2.3.1.26) (cholesterol acyltransferase 2) (acyl coenzyme a:cholesterol acyltransferase 2) (acat-2). [source:swissprot;acc:o75908]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7643.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7974.94\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0434\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
692\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, gamma-2 subunit (ampk gamma-2 chain) (ampk gamma2) (h91620p). [source:swissprot;acc:q9ugj0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6920.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7747.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 2; homer homolog 3 (drosophila). [source:refseq;acc:nm\_004839]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7229.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7542.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04338\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
693\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
j kappa-recombination signal binding protein (rbp-j kappa). [source:swissprot;acc:q06330]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7725.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8647.74\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11943\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sterol o-acyltransferase 1 (ec 2.3.1.26) (cholesterol acyltransferase 1) (acyl coenzyme a:cholesterol acyltransferase 1) (acat-1). [source:swissprot;acc:p35610]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7644.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7976.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04338\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
694\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
human immunodeficiency virus type i enhancer binding protein 3. [source:refseq;acc:nm\_024503]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7725.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8647.74\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11943\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ring finger protein 10. [source:refseq;acc:nm\_014868]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7644.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7976.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04338\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
695\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 35, member b2; 3'-phosphoadenosine 5'-phosphosulfate transporter. [source:refseq;acc:nm\_178148]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8810.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9191.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0433\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 40 (human immunodeficiency virus type i enhancer- binding protein 1) (hiv-ep1) (major histocompatibility complex binding protein 1) (mbp-1) (positive regulatory domain ii binding factor 1) (prdii-bf1). [source:swissprot;acc:p15822]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7725.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8647.74\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11943\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
696\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aminoacylase-1 (ec 3.5.1.14) (n-acyl-l-amino-acid amidohydrolase) (acy-1). [source:swissprot;acc:q03154]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8004.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8350.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04329\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
human immunodeficiency virus type i enhancer-binding protein 2 (hiv-ep2). [source:swissprot;acc:p31629]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7725.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8647.74\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11943\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
697\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
enteropeptidase precursor (ec 3.4.21.9) (enterokinase). [source:swissprot;acc:p98073]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7691.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8024.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04323\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 2 (sh3 domain protein 2a) (endophilin 1) (een-b1). [source:swissprot;acc:q99962]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7105.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7953.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11941\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
698\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
armet protein precursor (arginine-rich protein). [source:swissprot;acc:p55145]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7101.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7949.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11939\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
polyamine oxidase isoform 1; polyamine oxidase; flavin-containing spermine oxidase; putative cyclin g1 interacting protein; flavin containing amine oxidase. [source:refseq;acc:nm\_019025]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8800.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9180.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0432\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
699\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histidine decarboxylase (ec 4.1.1.22) (hdc). [source:swissprot;acc:p19113]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7101.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7949.84\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11939\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ponsin; sh3-domain protein 5 (ponsin). [source:refseq;acc:nm\_015385]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7624.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7952.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04313\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
700\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s28. [source:swissprot;acc:p25112]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7161.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8015.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11936\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial carrier protein mgc4399. [source:refseq;acc:nm\_032315]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8059.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8406.81\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04311\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
701\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cathepsin l2 precursor (ec 3.4.22.43) (cathepsin v) (cathepsin u). [source:swissprot;acc:o60911]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7280.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7593.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04303\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
importin-alpha re-exporter (chromosome segregation 1-like protein) (cellular apoptosis susceptibility protein). [source:swissprot;acc:p55060]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7802.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8731.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11913\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
702\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lbp-9. [source:refseq;acc:nm\_014553]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7067.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7371.74\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04303\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 3 (sh3 domain protein 2c) (een-b2). [source:swissprot;acc:q99963]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7067.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7909.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11911\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
703\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial intermediate peptidase, mitochondrial precursor (ec 3.4.24.59) (mip). [source:swissprot;acc:q99797]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8539.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8906.94\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04303\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nascent-polypeptide-associated complex alpha polypeptide. [source:refseq;acc:nm\_005594]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6912.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7735.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11899\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
704\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-nac protein. [source:sptrembl;acc:q9h009]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6912.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7734.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11898\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor cp2; transcription factor cp2, alpha globin. [source:refseq;acc:nm\_005653]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7068.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7372.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04302\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
705\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-amylase, salivary precursor (ec 3.2.1.1) (1,4-alpha-d-glucan glucanohydrolase). [source:swissprot;acc:p04745]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7068.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7372.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04301\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
small gtp-binding tumor suppressor 1. [source:refseq;acc:nm\_145173]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6912.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7734.41\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11897\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
706\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
di-ras2. [source:refseq;acc:nm\_017594]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6912.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7734.39\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
elongation factor 1-beta (ef-1-beta). [source:swissprot;acc:p24534]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7733.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8066.07\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04301\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/